ACS Omega · 2018 · 216 citations · 21 references
PharmacyBiomedical EngineeringPharmaceuticsDrug DeliveryNanoparticle Drug DeliveryNanotechnologyCancer NanomedicineLipid-based Drug Delivery SystemsLipid-based NanoparticlesNanomedicineNanoparticle Delivery SystemsSmall Interfering Rna DeliveryDrug Delivery NanocarriersLipid NanocarriersLipid Nanoparticle DeliveryLipid Nanoparticle Delivery SystemsLipid NanoparticlesMicromixer DesignNanoparticle DeliverySize Control
The precise size control of the lipid nanoparticle (LNP)-based nanodrug delivery system (DDS) carriers, such as 10 nm size tuning of LNPs, is one major challenge for the development of next-generation nanomedicines. Size-controlled LNPs would realize size-selective tumor targeting and deliver DNA and RNA to target tumor tissues effectively by passing through the stromal cells. Herein, we developed a baffle mixer device named the invasive lipid nanoparticle production device, or iLiNP device for short, which has a simple two-dimensional microchannel and mixer structure, and we achieved the first reported LNP size tuning at 10 nm intervals in the size range from 20 to 100 nm. In comparison with the conventional LNP preparation methods and reported micromixer devices, our iLiNP device showed better LNP size controllability, robustness of device design, and LNP productivity. Furthermore, we prepared 80 nm sized LNPs with encapsulated small interfering RNA (siRNA) using the iLiNP device; these LNPs effectively performed as nano-DDS carriers in an in vivo experiment. We expect iLiNP devices will become novel apparatuses for LNP production in nano-DDS applications.
21
Chaotic Mixer for Microchannels
Abraham D. Stroock, Stephan K. W. Dertinger, Armand Ajdari et al. · Science · 2002 · 3.4K citations
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
Horacio Cabral, Yu Matsumoto, Kazue Mizuno et al. · Nature Nanotechnology · 2011 · 2.4K citations
Pharmacy, Oncology, Pharmacokinetics +14